PMID- 8902581 OWN - NLM STAT- MEDLINE DCOM- 19970214 LR - 20190817 IS - 0047-1828 (Print) IS - 0047-1828 (Linking) VI - 60 IP - 9 DP - 1996 Sep TI - Dipyridamole suppresses catecholamine- and Ca++ influx-sensitive ventricular arrhythmias. PG - 629-40 AB - To study the mechanism of ventricular arrhythmias, the effect of dipyridamole (DIP; 300 mg/day), an adenosine transport inhibitor, on ventricular premature contractions (VPCs) was assessed in 12 patients who showed VPCs (21312 +/- 12314/day) on Holter ECG in a controlled setting. The effects were compared with those of verapamil (240 mg/day) and bisoprolol (5 mg/day). DIP suppressed more than one-half the VPCs in 5 patients. The mean degree of reduction in these DIP-responders was 75 +/- 18%. Both verapamil and bisoprolol inhibited VPCs in all of the DIP-responders (verapamil: 71 +/- 15%, bisoprolol: 88 +/- 16%). Two of the 5 DIP-responders had sustained ventricular tachycardias (VT) that were terminated by intravenous DIP, ATP, acetylcholine, verapamil, and propranolol. In contrast, verapamil did not inhibit VPCs in any of the DIP-nonresponders. Bisoprolol also did not suppress VPCs in 3 of 6 DIP-non responders. heart rate was unaffected by DIP, but was suppressed by both verapamil and bisoprolol. In addition, DIP increased the serum concentration of adenosine (control 16.3 +/- 17.1 vs 22.3 +/- 19.0 pmol/ml after DIP, p < 0.05). The inhibitory effect of DIP may involve suppression of Ca+2 current through an extracellular increase in adenosine. FAU - Kobayashi, Y AU - Kobayashi Y AD - Third Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan. FAU - Miyata, A AU - Miyata A FAU - Chiyoda, K AU - Chiyoda K FAU - Nakagawa, H AU - Nakagawa H FAU - Jinbo, Y AU - Jinbo Y FAU - Tanno, K AU - Tanno K FAU - Kikushima, S AU - Kikushima S FAU - Kurano, K AU - Kurano K FAU - Baba, T AU - Baba T FAU - Katagiri, T AU - Katagiri T LA - eng PT - Journal Article PL - Japan TA - Jpn Circ J JT - Japanese circulation journal JID - 7806868 RN - 0 (Catecholamines) RN - 0 (Vasodilator Agents) RN - 64ALC7F90C (Dipyridamole) RN - CJ0O37KU29 (Verapamil) RN - SY7Q814VUP (Calcium) SB - IM MH - Adult MH - Aged MH - Biological Transport MH - Calcium/*metabolism MH - Catecholamines/*metabolism MH - Dipyridamole/pharmacology/*therapeutic use MH - Female MH - Humans MH - Male MH - Middle Aged MH - Myocardial Contraction/drug effects MH - Vasodilator Agents/pharmacology/*therapeutic use MH - Ventricular Fibrillation/*drug therapy/metabolism/physiopathology MH - Verapamil/pharmacology/therapeutic use EDAT- 1996/09/01 00:00 MHDA- 1996/09/01 00:01 CRDT- 1996/09/01 00:00 PHST- 1996/09/01 00:00 [pubmed] PHST- 1996/09/01 00:01 [medline] PHST- 1996/09/01 00:00 [entrez] AID - 10.1253/jcj.60.629 [doi] PST - ppublish SO - Jpn Circ J. 1996 Sep;60(9):629-40. doi: 10.1253/jcj.60.629.